APA

Gogas H., Bafaloukos D., Ioannovich J., Skarlos D., Polyzos A., Fountzilas G., Kalofonos H. P., Aravantinos G., Tsoutsos D., Panagiotou P., Frangia K., Petrakopoulou T. & Pectasides D. (20040909). Tolerability of adjuvant high-dose interferon alfa-2b: 1 month versus 1 year--a Hellenic Cooperative Oncology Group study. : Anticancer research.

Chicago

Gogas Helen, Bafaloukos Dimitrios, Ioannovich John, Skarlos Dimosthenis, Polyzos Aris, Fountzilas George, Kalofonos Haralambos P, Aravantinos Gerassimos, Tsoutsos Dimosthenis, Panagiotou Petros, Frangia Konstantina, Petrakopoulou Theodora and Pectasides Dimitrios. 20040909. Tolerability of adjuvant high-dose interferon alfa-2b: 1 month versus 1 year--a Hellenic Cooperative Oncology Group study. : Anticancer research.

Harvard

Gogas H., Bafaloukos D., Ioannovich J., Skarlos D., Polyzos A., Fountzilas G., Kalofonos H. P., Aravantinos G., Tsoutsos D., Panagiotou P., Frangia K., Petrakopoulou T. and Pectasides D. (20040909). Tolerability of adjuvant high-dose interferon alfa-2b: 1 month versus 1 year--a Hellenic Cooperative Oncology Group study. : Anticancer research.

MLA

Gogas Helen, Bafaloukos Dimitrios, Ioannovich John, Skarlos Dimosthenis, Polyzos Aris, Fountzilas George, Kalofonos Haralambos P, Aravantinos Gerassimos, Tsoutsos Dimosthenis, Panagiotou Petros, Frangia Konstantina, Petrakopoulou Theodora and Pectasides Dimitrios. Tolerability of adjuvant high-dose interferon alfa-2b: 1 month versus 1 year--a Hellenic Cooperative Oncology Group study. : Anticancer research. 20040909.